Table 6.
Clinical Outcome Measures
| Author Year | Clinical Failure
|
Clinical Failure
|
Overall IKDC A or B
|
Overall IKDC A or B
|
Normal Lachman
|
Normal Lachman
|
Normal Pivot
|
Normal Pivot
|
KT-1000 within 2–4 mm of contra- lateral
|
KT-1000 within 2–4 mm of contra- lateral
|
No extension deficit
|
No extension deficit
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BTB | Ham | BTB | Ham | BTB | Ham | BTB | Ham | BTB | Ham | BTB | Ham | |
|
| ||||||||||||
| Ibrahim 2005 | NR | NR | 35/40 (88 %) | 38/45 (84 %) | 35/40 (88 %) | 39/45 (87 %) | 35/40 (88 %) | 38/45 (84%) | 35/40 (88 %) | 38/45 (84 %) | 28/40 (70 %) | 37/45 (82 %) |
|
| ||||||||||||
| Keays 2007 | 0/29 (0%) | 1/27 (3.7%) | 29/29* (100 %) | 25/25* (100 %) | 29/29* (100 %) | 25/25* (100 %) | 23/27# (85 %) | 18/22# (82 %) | 29/29* (100 %) | 25/25* (100 %) | ||
|
| ||||||||||||
| Liden 2007 | 2/32 (6.2%) | 2/36 (5.6%) | 15/31* (48 %) | 17/34* (50 %) | 30/31* (97 %) | 32/34* (94 %) | NR | NR | NR | NR | 24/31* (77 %) | 27/34* (79 %) |
|
| ||||||||||||
| O’Neill 2001 | 9/150 (6.0%) | 6/75 (8.0%) | 141/150 (94 %) | 67/75 (89 %) | NR | NR | NR | NR | 121/150 (81 %) | 56/75 (75 %) | NR | NR |
|
| ||||||||||||
| Roe 2005 | 4/90 (4.4%) | 9/90 (10%) | 50/59# (85 %) | 54/61# (89 %) | 45/59# (76 %) | 50/61# (82 %) | 49/59# (83 %) | 50/61# (82 %) | 44/59# (74 %) | 49/61# (80 %) | 51/59# (86 %) | 55/61# (90 %) |
|
| ||||||||||||
| Sajovic 2006 | 1/30 (3.3%) | 1/31 (3.2%) | 25/26# (97 %) | 27/28# (97 %) | 22/26# (85 %) | 22/28# (79 %) | 21/26# (81 %) | 23/28# (83 %) | 21/26# (81 %) | 24/28# (85 %) | NR | NR |
|
| ||||||||||||
| Zaffagnini 2006 | NR | NR | 19/25 (76 %) | 18/25 (72 %) | 22/25 (88 %) | 16/25 (64 %) | 23/25 (92 %) | 18/25 (72 %) | 18/25 (72 %) | 15/25 (60 %) | 20/25 (80 %) | 18/25 (72 %) |
*
Clinical Failures Excluded
#
Clinical Failures and Contralateral Ruptures Excluded
NR = Not Reported